Fresenius SE & Co. KGaA Company Description
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients.
It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed.
The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services.
The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients.
This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products.
The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities.
This segment also offers operational management of healthcare facilities and provides services to patients.
The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011.
Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
Country | Germany |
Founded | 1912 |
Industry | Medical Care Facilities |
Sector | Healthcare |
Employees | 193,865 |
CEO | Michael Sen |
Contact Details
Address: Else-Kroener-Strasse 1 Bad Homburg vor der Höhe, 61352 Germany | |
Phone | 49 6172 6080 |
Website | fresenius.com |
Stock Details
Ticker Symbol | FRE |
Exchange | Deutsche Börse Xetra |
Fiscal Year | January - December |
Reporting Currency | EUR |
ISIN Number | DE0005785604 |
SIC Code | 8090 |
Key Executives
Name | Position |
---|---|
Pierluigi Antonelli | Member of Management Board of Fresenius Management SE and Chief Executive Officer of Fresenius Kabi |
Michael Sen | Chief Executive Officer, President and Chairman of Management Board of Fresenius Management SE |
Sara Lisa Hennicken | Chief Financial Officer and Member of the Management Board - Fresenius Management SE |
Dr. Michael Sven Moser Ph.D. | Member of Management Board of Fresenius Management SE |
Robert Moller | Member of the Management Board of Fresenius Management SE |
Nick Stone | Senior Vice President of Investor Relations and Head of Investor Relations - Fresenius Management SE |
Matthias Link | Senior Vice President Corporate Communications |
Sebastian Schlagwein | Head of Group ESG |